Alex Nemiroff Biography and Net Worth

General Counsel of Praxis Precision Medicines

Alex Nemiroff, J.D., has served as our General Counsel since June 2020. Prior to his role as General Counsel, Mr. Nemiroff served as our Vice President of Legal from January 2020 to June 2020. Mr. Nemiroff was also a co-founder of RogCon, Inc. and RogCon U.R., Inc., and he has served as both entities’ Chief Executive Officer since inception in November 2015. Mr. Nemiroff has experience working in commercial and securities litigation while at Greenberg Traurig LLP, and served as law clerk to the Honorable Paul C. Huck of the United States District Court for the Southern District of Florida. Mr. Nemiroff received a B.B.A from the University of Michigan’s Ross School of Business, and a J.D. from Northwestern University School of Law.

What is Alex Nemiroff's net worth?: The estimated net worth of Alex Nemiroff is at least $382,888.17 as of November 14th, 2024. Nemiroff owns 10,301 shares of Praxis Precision Medicines stock worth more than $382,888 as of May 13th. This net worth approximation does not reflect any other investments that Nemiroff may own. Additionally, Nemiroff receives a salary of $577,340.00 as General Counsel at Praxis Precision Medicines. Learn More about Alex Nemiroff's net worth.
How old is Alex Nemiroff?: Nemiroff is currently 44 years old. There are 4 older executives and no younger executives at Praxis Precision Medicines. The oldest executive at Praxis Precision Medicines is Mr. Timothy Edwin Kelly, CFO & Treasurer, who is 50 years old. Learn More on Alex Nemiroff's age.
What is Alex Nemiroff's salary?: As the General Counsel of Praxis Precision Medicines, Inc., Nemiroff earns $577,340.00 per year. There are 2 executives that earn more than Nemiroff. The highest earning executive at Praxis Precision Medicines is Mr. Marcio Silva De'Souza M.B.A., President, CEO & Director, who commands a salary of $1,180,000.00 per year. Learn More on Alex Nemiroff's salary.
How do I contact Alex Nemiroff?: The corporate mailing address for Nemiroff and other Praxis Precision Medicines executives is 101 MAIN STREET #1210, CAMBRIDGE MA, 02142. Praxis Precision Medicines can also be reached via phone at 617-300-8460 and via email at investors@praxismedicines.com. Learn More on Alex Nemiroff's contact information.
Has Alex Nemiroff been buying or selling shares of Praxis Precision Medicines?: Alex Nemiroff has not been actively trading shares of Praxis Precision Medicines in the last ninety days. Most recently, Alex Nemiroff sold 8,239 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $80.20, for a transaction totalling $660,767.80. Following the completion of the sale, the general counsel now directly owns 10,301 shares of the company's stock, valued at $826,140.20. Learn More on Alex Nemiroff's trading history.
Who are Praxis Precision Medicines' active insiders?: Praxis Precision Medicines' insider roster includes Jill Desimone (Director), Lauren Mastrocola (Insider), Alex Nemiroff (General Counsel), and Marcio Souza (CEO). Learn More on Praxis Precision Medicines' active insiders.
Are insiders buying or selling shares of Praxis Precision Medicines?: In the last twelve months, insiders at the sold shares 2 times. They sold a total of 13,427 shares worth more than $1,085,042.44. The most recent insider tranaction occured on November, 14th when General Counsel Alex Nemiroff sold 8,239 shares worth more than $660,767.80. Insiders at Praxis Precision Medicines own 2.7% of the company. Learn More about insider trades at Praxis Precision Medicines.
Information on this page was last updated on 11/14/2024.

Alex Nemiroff Insider Trading History at Praxis Precision Medicines

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/14/2024	Sell	8,239	$80.20	$660,767.80	10,301
6/13/2022	Buy	500	$24.45	$12,225.00	2,623

Alex Nemiroff Buying and Selling Activity at Praxis Precision Medicines

Praxis Precision Medicines Company Overview

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Today's Range

Now: $37.17

$36.73

$38.36

50 Day Range

MA: $35.63

$28.47

$40.24

2 Week Range

Now: $37.17

$26.70

$91.83

Volume

104,255 shs

Average Volume

490,051 shs

Market Capitalization

$757.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.65

Alex Nemiroff Biography and Net Worth

What is Alex Nemiroff's net worth?

How old is Alex Nemiroff?

What is Alex Nemiroff's salary?

How do I contact Alex Nemiroff?

Has Alex Nemiroff been buying or selling shares of Praxis Precision Medicines?

Who are Praxis Precision Medicines' active insiders?

Are insiders buying or selling shares of Praxis Precision Medicines?